Biotech Analyst Kim, along with Insmed’s Chief Product Strategy Officer, Gene Sullivan, discuss TPIP (Treprostinil Palmitil Inhalation Powder), a once-daily inhaled Treprostinil Prodrug and Insmed’s “Most Underappreciated Asset” on an Analyst/Industry conference call to be held on November 16 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INSM:
